GlassScriptPhysician profile
Keith A Ayrons
NPI 1831143775
$1,193.22
in general payments reported to CMS, 2019-2025
20 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $233 · 2021: $134 · 2022: $61.63 · 2023: $169 · 2024: $87.68 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $383 · Education: $25.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $383.07 |
| Education | $25.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $168.12 | 2020-2025 | Cabometyx |
| Janssen Biotech, INC. | $134.05 | 2019-2021 | |
| Astellas Pharma US INC | $124.02 | 2019-2023 | Padcev |
| Genentech USA, INC. | $107.75 | 2019-2025 | Phesgo, Tecentriq, Ocrevus Zunovo |
| Pfizer INC. | $96.78 | 2019-2025 | |
| Novocure INC. | $76.07 | 2019 | |
| Novartis Pharmaceuticals Corporation | $70.31 | 2020-2023 | |
| Eisai INC. | $51.21 | 2019-2022 | |
| Seagen INC. | $49.86 | 2021 | |
| Emd Serono, INC. | $40.50 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $38.89 | 2019-2021 | |
| Daiichi Sankyo INC. | $35.20 | 2020-2025 | Datroway |
| Amgen INC. | $34.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $32.40 | 2020 | |
| Incyte Corporation | $32.01 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacyclics LLC, An Abbvie Company | $28.76 | 2019-2020 | |
| Genmab U.S., INC. | $22.03 | 2025 | Epkinly |
| Glaxosmithkline, LLC. | $20.05 | 2025 | Ojjaara |
| Merck Sharp & Dohme LLC | $15.82 | 2019 | |
| Myriad Genetic Laboratories, INC. | $15.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Ayrons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.